{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:28:44Z","timestamp":1791300524197,"version":"4.1.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T00:00:00Z","timestamp":1365120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s10067-013-2244-0","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T08:40:17Z","timestamp":1365064817000},"page":"1095-1098","source":"Crossref","is-referenced-by-count":17,"title":["Adalimumab-associated antiphospholipid syndrome: a case report and review of the literature"],"prefix":"10.1007","volume":"32","author":[{"given":"Iman","family":"Hemmati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Kur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,5]]},"reference":[{"issue":"Suppl 1","key":"2244_CR1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ajh.23196","volume":"87","author":"TL Ortel","year":"2012","unstructured":"Ortel TL (2012) Antiphospholipid syndrome: laboratory testing and diagnostic strategies. Am J Hematol 87(Suppl 1):75\u201381, Review","journal-title":"Am J Hematol"},{"issue":"4","key":"2244_CR2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/annrheumdis-2011-201244","volume":"72","author":"GR Burmester","year":"2012","unstructured":"Burmester GR, Panaccione R, Gordon KB, McIlraith MJ, Lacerda AP (2012) Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn\u2019s disease. Ann Rheum Dis 72(4):517\u2013524","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2244_CR3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/03009740902832753","volume":"39","author":"E Vereckei","year":"2010","unstructured":"Vereckei E, Kriv\u00e1n G, R\u00e9ti M, Szodoray P, Po\u00f3r G, Kiss E (2010) Anti-TNF-alpha-induced anti-phospholipid syndrome manifested as necrotizing vasculitis. Scand J Rheumatol 39(2):175\u2013177","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"2244_CR4","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2230.2011.04242.x","volume":"37","author":"W Bakkour","year":"2012","unstructured":"Bakkour W, Coulson IH, Sahasrabudhe N (2012) Adalimumab-induced medium-sized vessel vasculitis. Clin Exp Dermatol 37(5):562\u2013564","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"2244_CR5","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1365-2133.2006.07195.x","volume":"154","author":"SD Orpin","year":"2006","unstructured":"Orpin SD, Majmudar VB, Soon C, Azam NA, Salim A (2006) Adalimumab causing vasculitis. Br J Dermatol 154(5):998\u2013999","journal-title":"Br J Dermatol"},{"issue":"5","key":"2244_CR6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4292\/wjgpt.v1.i5.119","volume":"1","author":"FZ Rahman","year":"2010","unstructured":"Rahman FZ, Takhar GK, Roy O, Shepherd A, Bloom SL, McCartney SA (2010) Henoch\u2013Sch\u00f6nlein purpura complicating adalimumab therapy for Crohn\u2019s disease. World J Gastrointest Pharmacol Ther 1(5):119\u2013122","journal-title":"World J Gastrointest Pharmacol Ther"},{"issue":"7","key":"2244_CR7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.crohns.2012.02.019","volume":"6","author":"I Marques","year":"2012","unstructured":"Marques I, Lagos A, Reis J, Pinto A, Neves B (2012) Reversible Henoch\u2013Sch\u00f6nlein purpura complicating adalimumab therapy. J Crohns Colitis 6(7):796\u2013799","journal-title":"J Crohns Colitis"},{"key":"2244_CR8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/09546630410017275","volume":"15","author":"N Scheinfeld","year":"2004","unstructured":"Scheinfeld N (2004) A comprehensive review and evaluation of the side effects of the tumor necrosis factor a blockers etanercept, infliximab and adalimumab. J Dermatolog Treat 15:280\u2013294","journal-title":"J Dermatolog Treat"},{"issue":"10","key":"2244_CR9","first-page":"2287","volume":"30","author":"SJ Jarrett","year":"2003","unstructured":"Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, Emery P (2003) Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. J Rheumatol 30(10):2287\u20132291","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2244-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-013-2244-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2244-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:25Z","timestamp":1559120245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-013-2244-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,5]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2244"],"URL":"https:\/\/doi.org\/10.1007\/s10067-013-2244-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,5]]}}}